After President Donald Trump used the word “retarded” recently, social media posts including the term tripled, fueling a trend that has disability advocates on edge. A new report finds that a ...
In late 2021, as the housing market overheated and the Federal Reserve’s benchmark interest rate hovered near zero, Tony Yang found an unconventional way to fund his down payment. He logged into his ...
Bruker Corporation today announced the launch of the VERTEX NEO Ultra, its most advanced and versatile benchtop vacuum Fourier-Transform Infrared (FT-IR) spectrometer. Building on the VERTEX NEO ...
Math enthusiasts would love to check out Google today! Wondering why? Well, it seems like the homepage is celebrating a widely used formula; ax2+bx+c=0! Nerdy enough to understand which equation this ...
The pressure is on Xabi Alonso to get Real Madrid back to winning ways. / Diego Souto/Getty Images Real Madrid head into the November international break off the back of back-to-back blunders, leaving ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The New York State Education Department is pushing new math guidelines, including a recommendation that teachers stop giving timed quizzes — because it stresses students out. The new guidelines also ...
In the third century BCE, Apollonius of Perga asked how many circles one could draw that would touch three given circles at exactly one point each. It would take 1,800 years to prove the answer: eight ...
Jenny Quinn, executive director of the Seattle Universal Math Museum, shows off a solved Fibonacci sequence puzzle. (GeekWire Photo / Maddie Stoll) Jenny Quinn travels with math in her backpack. She ...
What if the next new mathematical discovery didn’t come from a human mind, but from an AI? Imagine a machine not just crunching numbers but proposing original solutions to problems that have baffled ...
Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...